The emerging treatment of this peptide represents a exciting development in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide411350.blogdomago.com/40470886/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment